Evidence map›Paper›PMID 38527781›Full record

ReviewInfection & chemotherapy2024

Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID.

Jun-Won Seo, Seong Eun Kim, Yoonjung Kim, Eun Jung Kim, Tark Kim, Taehwa Kim, So Hee Lee, Eunjung Lee, Jacob Lee, Yu Bin Seo and 4 more

Open access · goldAbstract readReview
In one paragraph

Review in Infection & chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 3 pooled it
18.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 3 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Treatment with Sulodexide Downregulates Biomarkers for Endothelial Dysfunction in Convalescent COVID-19 Patients.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Trial
  6. Review
  7. Article
  8. Review
  9. Review
  10. Bridging Gaps in Long COVID Therapy: A Review.Current medicinal chemistry · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Assessment and management of post-COVID-19 pulmonary complications: a rapid review.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  16. Review
  17. Review
  18. Observational
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 11 institutions in 1 country.

Jun-Won SeoDivision of Infectious Diseases, Department of Internal Medicine, College of Medicine, Chosun University, Gwangju, Korea.ORCID https://orcid.org/0000-0002-2806-1863
Seong Eun KimDivision of Infectious Diseases, Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.ORCID https://orcid.org/0000-0003-0162-6155
Yoonjung KimDivision of Infectious Diseases, Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, Korea.ORCID https://orcid.org/0000-0002-7454-4014
Eun Jung KimHealth, Welfare, Family and Gender Equality Team, National Assembly Research Service, Seoul, Korea.ORCID https://orcid.org/0000-0003-2352-5267
Tark KimDivision of Infectious Diseases, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.ORCID https://orcid.org/0000-0002-8829-4183
Taehwa KimDivision of Pulmonology, Allergy and Critical Care Medicine, Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea.ORCID https://orcid.org/0000-0003-3722-0261
So Hee LeeDepartment of Psychiatry, National Medical Center, Seoul, Korea.ORCID https://orcid.org/0000-0002-9005-3207
Eunjung LeeDivision of Infectious Diseases, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-7724-8288
Jacob LeeDivision of Infectious Diseases, Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-7041-065X
Yu Bin SeoDivision of Infectious Diseases, Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-5183-1996
Young-Hoon JeongCAU Thrombosis and Biomarker Center, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, and Division of Cardiology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-0403-3726
Young Hee JungDepartment of Neurology, Myongji Hospital, Hanyang University College of Medicine, Goyang, Korea.ORCID https://orcid.org/0000-0002-8945-2200
Yu Jung ChoiDivision of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0009-0008-1933-5843
Joon Young SongDivision of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea. infection@korea.ac.kr.ORCID https://orcid.org/0000-0002-0148-7194
Hallym University Kangnam Sacred Heart Hospital · KRKorea University · KRSoonchunhyang University · KRChonnam National University Hospital · KRChosun University · KRChung-Ang University Hospital · KRKyungpook National University Hospital · KRMyongji Hospital · KRNational Assembly · KRNational Medical Center · KRSoonchunhyang University Hospital Seoul · KR

Funding

Korea Health Industry Development Institute HD22C2045
6 · The paper itself

Abstract

"Long COVID" is a term used to describe a condition when the symptoms and signs associated with coronavirus disease 2019 (COVID-19) persist for more than three months among patients infected with COVID-19; this condition has been reported globally and poses a serious public health issue. Long COVID can manifest in various forms, highlighting the need for appropriate evaluation and management by experts from various fields. However, due to the lack of clear clinical definitions, knowledge of pathophysiology, diagnostic methods, and treatment protocols, it is necessary to develop the best standard clinical guidelines based on the scientific evidence reported to date. We developed this clinical guideline for diagnosing and treating long COVID by analyzing the latest research data collected from the start of the COVID-19 pandemic until June 2023, along with the consensus of expert opinions. This guideline provides recommendations for diagnosis and treatment that can be applied in clinical practice, based on a total of 32 key questions related to patients with long COVID. The evaluation of patients with long COVID should be comprehensive, including medical history, physical examination, blood tests, imaging studies, and functional tests. To reduce the risk of developing long COVID, vaccination and antiviral treatment during the acute phase are recommended. This guideline will be revised when there is a reasonable need for updates based on the availability of new knowledge on the diagnosis and treatment of long COVID.

Indexed as

Long COVIDManagementPersistent symptomsPost-COVID conditionSARS-CoV-2

Identifiers

PMID38527781
PMCPMC10990882
OpenAlexW4392963625

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.